Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00172003
What this trial is testing

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

Who this might be right for
Renal Cell CancerNeoplasm Metastasis
Novartis Pharmaceuticals 50
Not applicableStudy completedNCT03942497
What this trial is testing

Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America

Who this might be right for
Recurrent/Metastatic Urothelial Cancers
Latin American Cooperative Oncology Group 218
Not applicableStudy completedNCT02276924
What this trial is testing

Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors

Who this might be right for
HematuriaNephrolithiasisCancer of Urinary Tract+1 more
Lille Catholic University 29
Not applicableWithdrawnNCT00908739
What this trial is testing

Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Post-approval studies (Phase 4)Study completedNCT00706706
What this trial is testing

Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Pfizer 105
Testing effectiveness (Phase 2)Study completedNCT02843607
What this trial is testing

Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer

Who this might be right for
Metastatic Renal Cell Cancer
Fuda Cancer Hospital, Guangzhou 30
Early research (Phase 1)Study completedNCT00005816
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
Duke University 15
Not applicableStudy completedNCT05735977
What this trial is testing

Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared

Who this might be right for
Wilms TumorRenal Cancer
Birmingham Women's and Children's NHS Foundation Trust 12
Not applicableStudy completedNCT05195411
What this trial is testing

Vascular Thrombus Involvement in Nephroblastoma

Who this might be right for
Nephroblastoma With Vena Cava Thrombosis
Assistance Publique - Hôpitaux de Paris 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04645680
What this trial is testing

Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+7 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)UnknownNCT04903873
What this trial is testing

Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorRenal Cell Cancer MetastaticNon-Small Cell Lung Cancer+2 more
Eutilex 110
Early research (Phase 1)Study completedNCT00471432
What this trial is testing

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Who this might be right for
Bladder CancerBreast CancerKidney Cancer+4 more
NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03647163
What this trial is testing

Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerNeuroendocrine Carcinoma+1 more
Vyriad, Inc. 33
Not applicableStudy completedNCT04143230
What this trial is testing

Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool

Who this might be right for
Locally Advanced CancerMetastatic CancerChronic Respiratory Failure+3 more
A.O.U. Città della Salute e della Scienza 660
Not applicableEnded earlyNCT03709771
What this trial is testing

Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease

Who this might be right for
Renal Cell CarcinomaHypertensionMelanoma+1 more
Vanderbilt University Medical Center 2
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Early research (Phase 1)Study completedNCT00671411
What this trial is testing

Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast

Who this might be right for
Renal CancerKidney Cancer
Memorial Sloan Kettering Cancer Center 42
Large-scale testing (Phase 3)Study completedNCT00502034
What this trial is testing

Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.

Who this might be right for
Carcinoma, Renal Cell
Gruppo Oncologico Italiano di Ricerca Clinica 310
Next Page